'On consolidated basis
Quarter ended December 2025 compared with Quarter ended December 2024.
Net sales (including other operating income) of Divis Laboratories has increased 12.29% to Rs 2604 crore. Operating profit margin has jumped from 32.04% to 34.18%, leading to 19.78% rise in operating profit to Rs 890.00 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 42.22% to 42.32%. Employee cost increased from 12.28% to 12.76%. Other expenses fell from 14.76% to 13.98%.
Other income rose 7.32% to Rs 88 crore. PBIDT rose 18.55% to Rs 978 crore. Provision for interest remained nil.
PBDT rose 17.82% to Rs 972 crore. Provision for depreciation rose 19.19% to Rs 118 crore.
Profit before tax grew 17.63% to Rs 854.00 crore. Share of profit/loss were nil in both the periods. Pro...
Pleaselogin & subscribe to view the full report.
More Reports
-
(26-Feb-2026)
Foseco India
Net down 35% on higher EO Exp
-
(26-Feb-2026)
KSB
Net up 11%, sales up 8%
-
(26-Feb-2026)
Sanofi India
OP down 23.67%
-
(25-Feb-2026)
Schaeffler India
Revenue jumps 28% and profit spurts 36% in Q4CY25
|
|